Translational Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2023-07-04 bochia 来自陕西省

with editor已经15天了，写信没有任何回复。

27 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2023-05-15 ms9000001676536897 来自江苏省

偏重的研究方向：肿瘤;生信
经验分享：这个期刊生信加实验还收吗?

33 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2021-08-09 146a1aa7m17(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;预测
经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊

67 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2021-01-29 14727ed4m21(暂无昵称)

11.29投稿，1.28直接接收，速度很快

124 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2022-09-13 ms2000000214848895

从投稿到现在，已经三个月了，还是under review，我了个去。。。

38 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2022-02-12 12133f96m16(暂无昵称)

witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2021-05-29 ms1000000930252947

请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗

60 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2021-02-02 12133f96m16(暂无昵称)

求助，是不是必须各个作者邮箱确认啊？！！

91 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2020-11-01 my hero

with editor 快20天了，什么鬼啊

108 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2146234, encodeId=fc78214623451, content=with editor已经15天了，写信没有任何回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=38d95490431, createdName=bochia, createdTime=Tue Jul 04 08:50:12 CST 2023, time=2023-07-04, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2134713, encodeId=5cc42134e1325, content=偏重的研究方向：肿瘤;生信 经验分享：这个期刊生信加实验还收吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65408150838, createdName=ms9000001676536897, createdTime=Mon May 15 16:11:22 CST 2023, time=2023-05-15, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1006359, encodeId=67f81006359da, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;预测 经验分享：6-5提交，7-14修回，8-9接收；整体还算很快的。审稿人意见很中肯，不错的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85bc5154161, createdName=146a1aa7m17(暂无昵称), createdTime=Mon Aug 09 16:11:43 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921029, encodeId=427c9210298a, content=11.29投稿，1.28直接接收，速度很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93665195832, createdName=14727ed4m21(暂无昵称), createdTime=Fri Jan 29 13:46:18 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248592, encodeId=2e221248592f0, content=从投稿到现在，已经三个月了，还是under review，我了个去。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14776412369, createdName=ms2000000214848895, createdTime=Tue Sep 13 08:52:44 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192647, encodeId=c177119264e77, content=witheditor已经半个月了。？？？谁知道这后面怎么弄，要不要提醒一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sat Feb 12 12:12:37 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969425, encodeId=2d0b9694253f, content=请问单基因生信分析，没有做基础实验验证，可以投这个杂志吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac955437179, createdName=ms1000000930252947, createdTime=Sat May 29 12:50:18 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922185, encodeId=9861922185ff, content=求助，是不是必须各个作者邮箱确认啊？！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Tue Feb 02 14:03:08 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896002, encodeId=a329896002d1, content=with editor 快20天了，什么鬼啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fee72351294, createdName=my hero, createdTime=Sun Nov 01 10:05:44 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201398, encodeId=85d3220139899, content=偏重的研究方向：乳腺癌;癌症 经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Wed May 01 20:39:47 CST 2024, time=2024-05-01, status=1, ipAttribution=上海)]

2024-05-01 ms7000000417591078 来自上海

偏重的研究方向：乳腺癌;癌症
经验分享：营销号推荐才投的，但是实际审稿太慢，做好半年以上的准备

28 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务